The Biopharmaceutical practice at Kineticos assists growth-oriented pharmaceutical and biotech companies realize their commercial potential at the corporate, portfolio and product levels. Our consulting team has a depth of expertise across functional areas and therapeutic areas, established through decades of work in consulting or in industry. Overall the practice has a strong commitment to client satisfaction and a proven ability to deliver results through practical solutions.
The Biopharmaceutical Practice at Kineticos supports clients across six service areas including:
Corporate Strategy
- R&D Strategy
- Commercial Assessment
- Primary Market Research
Corporate Development
- In-licensing
- Out-licensing
- Transaction Support
Commercial Strategy
- Business Model Design
- Market Access
- Forecasting
Medical Affairs Effectiveness
- MSL Strategies and Solutions
- Organization Models
- Business Requirements
Commercial Performance
- Planning and Execution
- Commercial Operations
- Omni-channel Strategies
HCP and Patient Engagement
- Customer Experience
- Advocacy Relations
- Congress Planning
Click the Tabs Below for Biopharmaceutical Practice Case Studies
Corporate Strategy
Business Model Design
Situation: A specialty pharmacy company focused in rare hematological disorders needed support and guidance establishing their ex-US commercialization strategy. The sponsor had recently experienced a successful US launch but required support evaluating commercialization models for Canada. The sponsor established some foundational assumptions regarding the market opportunity but needed specific expertise to tease out the unique … Continue reading Business Model Design
Indication Prioritization and Forecasting
Situation: A publicly traded Oncology company with 3 technology platforms and limited resources was in need of narrowing their indication focus. Their next generation cancer vaccine technology demonstrated early proof of principle in 14 unique tumor types and retained Kineticos to conduct an indication prioritization exercise. The primary objective of the engagement was to objectively … Continue reading Indication Prioritization and Forecasting
Portfolio Optimization
Situation: A fully integrated pharmaceutical company developing a class of immuno-oncology therapies was in need of a deeper understanding of one of their program’s differentiating attributes. Several indications were under consideration and before further investing in clinical and commercial activities, the sponsor needed to gain insights into available therapies, what drives prescriber decisions, and how … Continue reading Portfolio Optimization
Portfolio Prioritization – Oncology
Situation: A publicly traded Oncology company with 3 technology platforms and limited resources was in need of narrowing their focus. Their next generation cancer vaccine technology had applicability to 14 unique cancer tumor types but given the need to narrow their focus, the sponsor retained Kineticos to conduct a portfolio prioritization exercise. The primary objective … Continue reading Portfolio Prioritization – Oncology
Oncology Commercial Assessment – Melanoma
Situation: A clinical-stage oncology company with a potentially ground-breaking technology requested Kineticos to help determine which tumor type(s) had the greatest potential to demonstrate patient benefit. The sponsor was considering 2 tumor types internally and requested that Kineticos conduct a Commercial Assessment to help understand the patient journey, unmet need, and commercial potential of Melanoma … Continue reading Oncology Commercial Assessment – Melanoma
Product Search
Situation: A drug delivery technology company identified an opportunity to generate additional revenue by acquiring products to further develop and enhance their innovative technology. Thus, the executive management team hired Kineticos to conduct a scan of the market with a goal of identifying attractive investment opportunities. Process: Kineticos initially focused on becoming very familiar … Continue reading Product Search
Corporate Development
Portfolio Optimization
Situation: A fully integrated pharmaceutical company developing a class of immuno-oncology therapies was in need of a deeper understanding of one of their program’s differentiating attributes. Several indications were under consideration and before further investing in clinical and commercial activities, the sponsor needed to gain insights into available therapies, what drives prescriber decisions, and how … Continue reading Portfolio Optimization
Portfolio Prioritization – Oncology
Situation: A publicly traded Oncology company with 3 technology platforms and limited resources was in need of narrowing their focus. Their next generation cancer vaccine technology had applicability to 14 unique cancer tumor types but given the need to narrow their focus, the sponsor retained Kineticos to conduct a portfolio prioritization exercise. The primary objective … Continue reading Portfolio Prioritization – Oncology
Oncology Commercial Assessment – Melanoma
Situation: A clinical-stage oncology company with a potentially ground-breaking technology requested Kineticos to help determine which tumor type(s) had the greatest potential to demonstrate patient benefit. The sponsor was considering 2 tumor types internally and requested that Kineticos conduct a Commercial Assessment to help understand the patient journey, unmet need, and commercial potential of Melanoma … Continue reading Oncology Commercial Assessment – Melanoma
Product Search
Situation: A drug delivery technology company identified an opportunity to generate additional revenue by acquiring products to further develop and enhance their innovative technology. Thus, the executive management team hired Kineticos to conduct a scan of the market with a goal of identifying attractive investment opportunities. Process: Kineticos initially focused on becoming very familiar … Continue reading Product Search
Commercial Assessment
Situation: A clinical-stage oncology company with a potentially ground-breaking technology requested Kineticos to help determine which tumor type(s) had the greatest potential to demonstrate patient benefit. The sponsor was considering 2 tumor types internally and requested that Kineticos conduct a Commercial Assessment to help understand the patient journey, unmet need, and commercial potential of Melanoma … Continue reading Commercial Assessment
Business Development and Licensing
Situation: A publicly traded pharmaceutical company seeking a strategic partner for their IND-ready asset was in need of support with executing on their partnering strategy. Thus, Kineticos was retained to lead and manage the business development and licensing process. Process: Kineticos was first charged with developing a clear and concise pitch deck to be leveraged … Continue reading Business Development and Licensing
Commercial Strategy
Commercial Strategy
Situation: A mid-size pharmaceutical company unexpectedly obtained a marketed CNS drug and needed to understand the financial impact of various commercialization strategies. Due to the newly acquired drug being in an adjacent market to the sponsor’s flagship product, there was uncertainty regarding investing in commercialization or eliminating from their product mix. Given the volatility of … Continue reading Commercial Strategy
Portfolio Optimization
Situation: A fully integrated pharmaceutical company developing a class of immuno-oncology therapies was in need of a deeper understanding of one of their program’s differentiating attributes. Several indications were under consideration and before further investing in clinical and commercial activities, the sponsor needed to gain insights into available therapies, what drives prescriber decisions, and how … Continue reading Portfolio Optimization
Portfolio Prioritization – Oncology
Situation: A publicly traded Oncology company with 3 technology platforms and limited resources was in need of narrowing their focus. Their next generation cancer vaccine technology had applicability to 14 unique cancer tumor types but given the need to narrow their focus, the sponsor retained Kineticos to conduct a portfolio prioritization exercise. The primary objective … Continue reading Portfolio Prioritization – Oncology
Oncology Commercial Assessment – Melanoma
Situation: A clinical-stage oncology company with a potentially ground-breaking technology requested Kineticos to help determine which tumor type(s) had the greatest potential to demonstrate patient benefit. The sponsor was considering 2 tumor types internally and requested that Kineticos conduct a Commercial Assessment to help understand the patient journey, unmet need, and commercial potential of Melanoma … Continue reading Oncology Commercial Assessment – Melanoma
Business Development & Licensing
Situation: An innovative oncology diagnostics company retained Kineticos to assist in developing their pitch deck, as well as developing and executing an outreach strategy designed to secure partnering meetings with key decision makers at biopharmaceutical companies and ultimately, boost revenue for the organization. The sponsor’s technology was validated through existing partnerships and there were internal … Continue reading Business Development & Licensing
Product Search
Situation: A drug delivery technology company identified an opportunity to generate additional revenue by acquiring products to further develop and enhance their innovative technology. Thus, the executive management team hired Kineticos to conduct a scan of the market with a goal of identifying attractive investment opportunities. Process: Kineticos initially focused on becoming very familiar … Continue reading Product Search